Research location
Headington
Oxford, United Kingdom
Advertisement
Research activity in Headington
Oxford, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 14 trials and 14 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Headington
14 linked trials · page 1 of 1Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.NCT07148128 · 2025-07-28 · 1 site observation
RECRUITING
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 DiabetesNCT04786262 · 2021-03-29 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)NCT04442503 · 2020-06-08 · 1 site observation
COMPLETED
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsNCT02797977 · 2016-07-01 · 1 site observation
COMPLETED
A Phase 1/2 Trial of SRA737 in Subjects With Advanced CancerNCT02797964 · 2016-07-01 · 1 site observation
COMPLETED
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype CharacteristicsNCT01972711 · 2014-03-01 · 1 site observation
COMPLETED
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsNCT01900652 · 2013-08-01 · 1 site observation
COMPLETED
A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)NCT01586624 · 2012-01-10 · 1 site observation
COMPLETED
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung CancerNCT01107444 · 2010-05-01 · 1 site observation
COMPLETED
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) GeneNCT00932451 · 2010-01-01 · 1 site observation
COMPLETED
Follow-Up Study for ExuberaNCT00734591 · 2008-08-01 · 1 site observation
COMPLETED
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlNCT00134147 · 2005-04-01 · 1 site observation
COMPLETED
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral TherapyNCT00004978 · 2000-03-01 · 1 site observation
COMPLETED
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV EventsNCT00327418 · 1997-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.